Jpmorgan Healthcare Leade... (JDOC)
NasdaqGM: JDOC
· Prix en temps réel · USD
61.83
-0.04 (-0.06%)
À la clôture : Aug 12, 2026, 9:37 AM
61.83
-0.07%
Après-Bourse: 4:10 PM
Jpmorgan Healthcare Leaders ETF (JDOC) ETF Price, Holdings & Analysis
-0.06% (1D)
| Bid | 43.72 |
| Capitalisation boursière | n/a |
| AUM | 9.07M |
| NAV | 61.97 |
| Bêta | n / A |
| EPS (ttm) | n / A |
| Rapport PE (ttm) | 29.16 |
| Parts en circulation | n / A |
| Date de création | Nov 1, 2023 |
| Ask | 77.81 |
| Volume | 62 |
| Moy. Volume (20D) | 398 |
| Ouverture | 61.83 |
| Clôture précédente | 61.87 |
| Fourchette du jour | 61.83 - 61.83 |
| Intervalle de 52 semaines | 50.34 - 62.45 |
| Positions | n / A |
| Ratio de frais | 0.65% |
À propos de JDOC
The fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market. Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of healthcare companies.
Classe d’actifs Equity
Symbole boursier JDOC
Date de création Nov 1, 2023
Fournisseur Jpmorgan
Site web Page d’accueil du fonds
Échange NasdaqGM
10 principaux titres 48.10% des actifs
| Nom | Symbole | Poids |
|---|---|---|
| Abbvie Inc | ABBV | 7.85% |
| Eli Lilly And Co | LLY | 7.76% |
| Unitedhealth Group I... | UNH | 5.85% |
| Merck & Co Inc | MRK | 4.82% |
| Johnson & Johnson | JNJ | 4.82% |
| Astrazeneca PLC | AZN.L | 3.76% |
| Thermo Fisher Scient... | TMO | 3.73% |
| Bristol-myers Squibb... | BMY | 3.57% |
| Abbott Laboratories | ABT | 3.11% |
| Cvs Health Corp | CVS | 2.83% |
Dividendes Rendement du dividende 0.83%
| Ex-dividende | Montant | Date de paiement |
|---|---|---|
| Dec 16, 2025 | $0.5120 | n / A |
| Dec 24, 2024 | $0.3280 | n / A |
| Dec 16, 2024 | $2.4890 | n / A |
| Dec 19, 2023 | $0.0800 | n / A |